Back to top
more

McKesson (MCK)

(Delayed Data from NYSE)

$485.42 USD

485.42
904,979

+3.15 (0.65%)

Updated Oct 4, 2024 04:00 PM ET

After-Market: $485.43 +0.01 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth D Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 32% (171 out of 252)

Industry: Medical - Dental Supplies

Better trading starts here.

Zacks News

Neogen (NEOG) Launches Test for Detection of Cashew Allergen

Neogen's (NEOG) new quantitative test shows a high level of specificity to very low levels of cashew protein (down to 0.2 ppm).

Exact Sciences (EXAS) Cologuard Business Grows Amid Cost Woes

Following the acquisitions of Paradigm and Ashion, Exact Sciences (EXAS) is now offering therapy selection tests for patients with advanced cancer.

The Zacks Analyst Blog Highlights Corteva, Hershey, National Fuel Gas and McKesson

Corteva, Hershey, National Fuel Gas and McKesson are included in this Analyst Blog.

Derek Lewis headshot

Defense Wins Ballgames; 3 Blue-Chip Stocks To Consider

Due to their well-established nature and track records of success, these companies are positioned to weather a dark fiscal cloud better than most.

QIAGEN (QGEN) Assays to Detect Organ Transplant-Related Viruses

QIAGEN's (QGEN) latest additions to the NeuMoDx assay menu will help identify EBV and HHV-6 viruses in immunocompromised patients.

3 Reasons to Hold QuidelOrtho (QDEL) Stock in Your Portfolio

Investors continue to be optimistic about QuidelOrtho (QDEL) owing to its strong product portfolio.

Teleflex (TFX) Witnesses Lower UroLift Sales, Cost Woes

Teleflex's (TFX) lowered revenue and adjusted EPS outlook for 2022 indicates lackluster performance, which increases investors' concern.

Abiomed's (ABMD) Impella-Related Research Gets FDA Clearance

Abiomed's (ABMD) latest regulatory clearances for clinical research of Impella heart pumps in AMI cardiogenic shock patients are expected to significantly improve patient outcomes.

3 Reasons to Hold Catalent (CTLT) Stock in Your Portfolio

Catalent's (CTLT) robust facility expansion activities and a slew of strategic deals raise optimism about the stock.

Snehadri Nag headshot

Beat the Market Vagaries With 4 Top-Ranked Defensive Bets

Grab these four defensive stocks, namely Corteva (CTVA), Hershey (HSY), National Fuel Gas Company (NFG) and McKesson (MCK), which hold strong potential.

Is SPDR Russell 1000 Momentum Focus ETF (ONEO) a Strong ETF Right Now?

Smart Beta ETF report for ONEO

3 Reasons to Hold Insulet (PODD) Stock in Your Portfolio

Investors continue to be optimistic about Insulet (PODD) on Omnipod's continued market access expansion.

Here's Why Investors Should Retain Integra (IART) Stock for Now

Investors are optimistic about Integra's (IART) better-than-expected results and the continued demand for its products.

Tandem Diabetes (TNDM) Faces Expense Woes, Macro Issues

Factoring in the pandemic and competitive pressure as well as evolving economic environment, including inflation and the threat of recession, Tandem Diabetes (TNDM) slashes full-year guidance.

Are Investors Undervaluing McKesson (MCK) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks.com featured highlights include American Airlines, CVREnergy, Builders FirstSource, McKesson and Beacon Roofing Supply

American Airlines, CVREnergy, Builders FirstSource, McKesson and Beacon Roofing Supply have been highlighted in this Screen of The Week article.

Zacks.com featured highlights Boise Cascade, Triton International, TotalEnergies, McKesson and RCI Hospitality Holdings

Boise Cascade, Triton International, TotalEnergies, McKesson and RCI Hospitality Holdings have been highlighted in this Screen of The Week article.

LHC Group's (LHCG) Latest Tie-Up to Improve Patient Services

LHC Group's (LHCG) latest JV is expected to expand the availability of vital healthcare services to patients in the comfort of their homes.

Here's Why Investors Should Retain Globus Medical (GMED) For Now

Investors are optimistic about Globus Medical's (GMED) better-than-expected results and new product introductions.

Here's Why You Should Retain PerkinElmer (PKI) Stock Now

PerkinElmer (PKI) continues to gain from solid product portfolio despite forex woes.

CVS Health (CVS) Progresses With Safe Medication Approach

A major feature of CVS Health's (CVS) time delay safe function is that it cannot be overridden and is designed to deter pharmacy robbers.

Here's Why You Should Retain Patterson Companies (PDCO) Stock

Investors remain optimistic about Patterson Companies (PDCO) on the back of its strong product line.

Phirbo (PAHC) Faces Rising Costs and Inflationary Pressure

Price competition coming from cheap generic alternatives of a few Phirbo (PAHC) products is a deterrent.

QIAGEN (QGEN) to Develop Companion Diagnostic for Neuron23

QIAGEN's (QGEN) novel companion diagnostic assay will help identify individuals who might benefit from Neuron23's drug candidate for Parkinson's disease.

The Zacks Analyst Blog Highlights NextEra Energy, The Southern, McKesson, PepsiCo and Archer-Daniels-Midland

NextEra Energy, The Southern, McKesson, PepsiCo and Archer-Daniels-Midland are included in this Analyst Blog.